Basic Information
Siduma Therapeutics was founded in 2021 by Craig Crews, Ph.D., a pioneer in PROTAC technology, with the aim of developing novel bifunctional small molecules to harness the innate biology of human cells for targeting various disease-causing proteins.
Siduma Therapeutics, Inc.
NewHaven,Connecticut,United States of America
less than 15 people
January 01, 2021
info@sidumathera.com

